Bioniche pharma trenbolone enanthate

Two double-blind, randomized studies compared the efficacy of a single 2 gram intravenous dose of Mefoxin to a single 2 gram intravenous dose of cefotetan in the prevention of surgical site-related infection (major morbidity) and non-site-related infections (minor morbidity) in patients following cesarean section. In the first study, 82/98 (%) patients treated with Mefoxin and 71/95 (%) patients treated with cefotetan experienced no major or minor morbidity. The difference in the outcomes in this study (95% CI: -, +) was not statistically significant. In the second study, 65/75 (%) patients treated with Mefoxin and 62/76 (%) patients treated with cefotetan experienced no major or minor morbidity. The difference in the outcomes in this study (95% CI: -, +) was not statistically significant.

Bioniche pharma trenbolone enanthate

bioniche pharma trenbolone enanthate

Media:

bioniche pharma trenbolone enanthatebioniche pharma trenbolone enanthatebioniche pharma trenbolone enanthatebioniche pharma trenbolone enanthatebioniche pharma trenbolone enanthate

http://buy-steroids.org